The SWTX Paradox: Analysts Bullish But Forecast -13.59% Fall
December 14, 2020 at 08:03 AM EST
Analyst ratings can sometimes be complicated, and we here at ETF Channel have noticed a bit of a paradox with SpringWorks Therapeutics Inc (SWTX). The average 12-month price target for SWTX — averaging the work of 4 analysts — reveals an average price target of $63.50/share..